Medivir focuses on the discovery and development of transformative cancer drugs. To do this efficiently and with a high success rate, we rely on our scientific knowledge, balanced project portfolio, collaborative culture and extensive industry experience.
Medivir is listed on the Nasdaq Stockholm Main Board.